Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity.
Frank MB, Yang Q, Osban J, Azzarello JT, Saban MR, Saban R, Ashley RA, Welter JC, Fung KM, Lin HK.
BMC Complement Altern Med. 2009 Mar 18;9(1):6. [Epub ahead of print]
PMID: 19296830
doi:10.1186/1472-6882-9-6
Chemopreventive and renal protective effects for docosahexaenoic acid (DHA): implications of CRP and lipid peroxides.
Elmesery ME, Algayyar MM, Salem HA, Darweish MM, El-Mowafy AM.
Cell Div. 2009 Apr 2;4(1):6. [Epub ahead of print]
PMID: 19341447
doi:10.1186/1747-1028-4-6
Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B12.
Ebbing M, Bønaa KH, Nygård O, Arnesen E, Ueland PM, Nordrehaug JE, Rasmussen K, Njølstad I, Refsum H, Nilsen DW, Tverdal A, Meyer K, Vollset SE.
JAMA. 2009 Nov 18;302(19):2119-2126. v
PMID: 19920236
Conclusion Treatment with folic acid plus vitamin B12 was associated with increased cancer outcomes and all-cause mortality in patients with ischemic heart disease in Norway, where there is no folic acid fortification of foods.
Rosmarinic acid antagonizes activator protein-1-dependent activation of cyclooxygenase-2 expression in human cancer and nonmalignant cell lines.
Scheckel KA, Degner SC, Romagnolo DF.
J Nutr. 2008 Nov;138(11):2098-105.
PMID: 18936204
Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials.
Block KI, Koch AC, Mead MN, Tothy PK, Newman RA, Gyllenhaal C
Int J Cancer. 2008 Sep 15;123(6):1227-39. Review.
PMID: 18623084
Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs.\nHeaney ML, Gardner JR, Karasavvas N, Golde DW, Scheinberg DA, Smith EA, O'Connor OA.\nCancer Res. 2008 Oct 1;68(19):8031-8.\nPMID: 18829561
Aldehyde dehydrogenase 2 and head and neck cancer: a meta-analysis implementing a Mendelian randomization approach.
Boccia S, Hashibe M, Gallì P, De Feo E, Asakage T, Hashimoto T, Hiraki A, Katoh T, Nomura T, Yokoyama A, van Duijn CM, Ricciardi G, Boffetta P.
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):248-54.
PMID: 19124505
doi: 10.1158/1055-9965.EPI-08-0462
Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma.
Jalili A, Pinc A, Pieczkowski F, Karlhofer FM, Stingl G, Wagner SN.
J Dtsch Dermatol Ges. 2008 Dec;6(12):1066-9. English, German.
PMID: 19138272
DOI: 10.1111/j.1610-0387.2008.06861.x
Schroeder CP, Yang P, Newman RA, Lotan R.
Eicosanoid metabolism in squamous cell carcinoma cell lines derived from primary and metastatic head and neck cancer and its modulation by celecoxib.
Cancer Biol Ther. 2004 Sep;3(9):847-52. Epub 2004 Sep 18.
P
Intravenous vitamin C as a chemotherapy agent: a report on clinical cases.\nRiordan HD, Riordan NH, Jackson JA, Casciari JJ, Hunninghake R, González MJ, Mora EM, Miranda-Massari JR, Rosario N, Rivera A.\nP R Health Sci J. 2004 Jun;23(2):115-8.\nPMID: 15377059
Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation.
Cao W, Yacoub S, Shiverick KT, Namiki K, Sakai Y, Porvasnik S, Urbanek C, Rosser CJ.
Prostate. 2008 Aug 1;68(11):1223-31.
PMID: 18465755
DOI: 10.1002/pros.20788